1nkemia IUCT Group SA
MAD:IKM

Watchlist Manager
1nkemia IUCT Group SA Logo
1nkemia IUCT Group SA
MAD:IKM
Watchlist
Price: 0.296 EUR Market Closed
Market Cap: €8m

Operating Margin

46.7%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
46.7%
=
Operating Income
€2.6m
/
Revenue
€5.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
46.7%
=
Operating Income
€2.6m
/
Revenue
€5.5m

Peer Comparison

Country Company Market Cap Operating
Margin
ES
1nkemia IUCT Group SA
MAD:IKM
7.9m EUR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Higher than 89% of companies in Spain
Percentile
89th
Based on 751 companies
89th percentile
46.7%
Low
-2 951.2% — 4.9%
Typical Range
4.9% — 19.6%
High
19.6% — 143.7%
Distribution Statistics
Spain
Min -2 951.2%
30th Percentile 4.9%
Median 12%
70th Percentile 19.6%
Max 143.7%

1nkemia IUCT Group SA
Glance View

Market Cap
8m EUR
Industry
Biotechnology

1nKemia IUCT Group SA engages in the research and development activities related to pharmaceutical, chemical, and biotechnology industries. The company is headquartered in Mollet Del Valles, Barcelona. The company went IPO on 2012-12-21. The firm provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Company’s activity is related to the generation, promotion, development and sale of products and services. The firm transforms its knowledge and know-how into a pipeline of products, processes, services and technological platforms. Its solutions are specialized, integrated and protected by patents. The main areas of expertise are related to drugs development, industrial biotechnology and green chemistry. The firm has a number of subsidiaries, including IUCT SA and IUCT Empren SL.

IKM Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
46.7%
=
Operating Income
€2.6m
/
Revenue
€5.5m
How has Operating Margin changed over time?

Over the last 3 years, 1nkemia IUCT Group SA’s Operating Margin has increased from -118.6% to 46.7%. During this period, it reached a low of -135.4% on Dec 31, 2016 and a high of 46.7% on Jan 31, 2019.

Back to Top